- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder Cancer Cell Transitional in Russian Federation
Total 289 results
-
I.M. Sechenov First Moscow State Medical UniversityCompletedBladder CancerRussian Federation
-
I.M. Sechenov First Moscow State Medical UniversityUnknownBladder CancerRussian Federation
-
BiocadUnknownMelanoma | Renal Cell Carcinoma | NSCLC | Bladder CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...The Foundation for Cancer Research Support (RakFond)RecruitingBladder CancerRussian Federation
-
Bristol-Myers SquibbCompletedTransitional Cell Carcinoma | Bladder Cancer | MetastasisUnited States, Korea, Republic of, United Kingdom, Spain, Australia, France, Thailand, Denmark, Poland, Belgium, Italy, Philippines, Canada, Russian Federation, Greece, Indonesia
-
Autonomous Non-Profit Organization National Society...RecruitingStage III Non-small Cell Lung CancerRussian Federation
-
Mona FrolovaUnknownEsophageal Neoplasms | Squamous Cell Carcinoma | Concurrent ChemoradiotherapyRussian Federation
-
Blokhin's Russian Cancer Research CenterRecruiting
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerRussian Federation
-
N.N. Blokhin National Medical Research Center of...RecruitingNon Small Cell Lung Cancer | EGFR Gene Mutation | T790MRussian Federation
-
Kidney Cancer Research BureauUnknownNon-small Cell Lung Cancer Metastatic | Pleural Effusion, Malignant | Renal Cell Cancer MetastaticRussian Federation
-
UroGen Pharma Ltd.TerminatedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel, Russian Federation, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Ukraine
-
CelgeneCompletedNon-Small Cell Lung Cancer (NSCLC)Russian Federation
-
BiocadActive, not recruitingMelanoma | Non Small Cell Lung CancerRussian Federation
-
Russian Academy of Medical SciencesRecruitingMelanoma | Hodgkin Lymphoma | Uveal Melanoma | Squamous Cell Lung CancerRussian Federation
-
Meshalkin Research Institute of Pathology of CirculationCompleted
-
NewVac LLCJanssen Pharmaceutica N.V., BelgiumCompletedEpithelial Ovarian Cancer | Non-small Cell Lung CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...RecruitingMelanoma | Lung Cancer | Pancreas Cancer | Refractory Cancer | Colorectal Cancer Recurrent | RAS Mutation | Ras (Kras or Nras) Gene MutationRussian Federation
-
N.N. Petrov National Medical Research Center of...Institute of Gene Biology Russian Academy of SciencesCompletedMelanoma | Kidney CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...European University at St. PetersburgActive, not recruitingMelanoma | Breast Cancer | Lung Cancer | Prostate Cancer | Cervix Cancer | Colon Cancer | Oncology | SurvivorshipRussian Federation
-
Catalysis SLCompletedNon-small Cell Lung Cancer Stage III | Gastric Cancer Stage III | Gastric Cancer Stage II | Non-small Cell Lung Cancer Stage IIKazakhstan, Russian Federation
-
BiocadUnknownNon Small Cell Lung Cancer Stage IIIB | Non-Small Cell Carcinoma of Lung, TNM Stage 4Russian Federation, Belarus
-
Shanghai Henlius BiotechActive, not recruitingExtensive Stage Small Cell Lung CancerChina, Georgia, Poland, Russian Federation, Turkey, Ukraine
-
N.N. Petrov National Medical Research Center of...RecruitingCervical Cancer | Human Papilloma Virus | Cervical DysplasiaRussian Federation
-
AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCRussian Federation
-
BiocadUnknownMelanoma | Renal Cell Carcinoma | Lung CancerRussian Federation
-
BIND TherapeuticsTerminatedCervical Cancer | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Urothelial CarcinomaRussian Federation, United States
-
AstraZenecaRecruitingNon-small-cell Lung CancerRussian Federation
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, France, Belgium, Israel, Spain, United Kingdom, Korea, Republic of, Taiwan, Australia, Netherlands, Japan, Germany, Ukraine, Canada, Ireland, Italy, Poland, Russian Federation
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, Spain, Hungary, Israel, United Kingdom, Korea, Republic of, Taiwan, Denmark, France, Netherlands, Italy, Canada, Japan, Turkey, Germany, Ireland, Australia, Russian Federation
-
AstraZenecaCompletedNon-Small Cell Lung CancerRussian Federation
-
Ascenta TherapeuticsCompletedNon-small Cell Lung CancerRussian Federation, United States, Ukraine
-
UCB PharmaCompletedCarcinoma | Non-Squamous Non-Small-Cell Lung CancerPoland, Russian Federation, Hungary
-
Mabscale, LLCRecruitingNon-Small Cell Lung CancerRussian Federation
-
Eli Lilly and CompanyWithdrawnMetastatic Squamous Non-Small Cell Lung Cancer | Locally Advanced Squamous Non-Small Cell Lung CancerItaly, Romania, Germany, Belgium, Russian Federation, United States, United Kingdom
-
AstraZenecaActive, not recruitingNon-muscle-invasive Bladder CancerFrance, Spain, Belgium, Canada, Poland, Germany, Japan, Russian Federation, United Kingdom, Austria, Australia, Netherlands
-
GlaxoSmithKlineCompletedLung Cancer, Small CellBulgaria, Hungary, Russian Federation, Netherlands, Ukraine, United Kingdom
-
Hoffmann-La RocheTerminatedCarcinoma, Transitional CellUnited States, Korea, Republic of, France, United Kingdom, Belgium, Canada, China, Greece, Spain, Turkey, Japan, Czechia, Israel, Italy, Russian Federation, Poland, Switzerland, Australia, Germany, Netherlands, Taiwan, Ukraine, Serbia, Finla...
-
BIND TherapeuticsCompletedNon-small Cell Lung CancerUnited States, Russian Federation
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CarcinomaFrance, United States, Korea, Republic of, Belgium, Taiwan, Turkey, Russian Federation, Spain, Italy, United Kingdom, Brazil, Belarus, Poland
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerFrance, Canada, United States, Russian Federation, Denmark
-
Ascenta TherapeuticsCompletedSmall Cell Lung CancerUnited States, Russian Federation, Ukraine
-
AmgenCompletedExtensive-Stage Small-Cell Lung CancerCanada, United States, Russian Federation
-
BayerCompletedCarcinoma, Transitional CellUnited States, Spain, Hungary, China, Belgium, Korea, Republic of, Taiwan, Australia, Singapore, Canada, Japan, Sweden, Russian Federation, Germany, Italy, Israel, Ireland, France, Austria, Denmark, Portugal, Switzerland, Czechia, Slo... and more
-
AstraZenecaRecruitingUnresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)Russian Federation
-
Axelar ABCompletedNon-small-cell Lung Cancer | Squamous Cell Carcinoma | Adenocarcinoma of the LungRussian Federation, Ukraine, Belarus, Hungary, Poland
-
Checkpoint Therapeutics, Inc.TerminatedMetastatic Non-squamous Non Small Cell Lung CancerPeru, Russian Federation, South Africa, New Zealand, Georgia, Thailand, Brazil, Malaysia
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerChina, Hong Kong, Russian Federation, Singapore
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesUnited States, Spain, Belgium, France, Germany, Italy, Korea, Republic of, Turkey, Hungary, Netherlands, Serbia, Poland, Russian Federation, Sweden, Moldova, Republic of, Denmark, Ukraine